Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com

StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research note released on Monday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reduced their price objective on shares of Aethlon Medical from $23.00 to $10.00 and set a buy rating for the company in a research note on Monday, March 4th.

Aethlon Medical Stock Performance

Shares of AEMD opened at $1.31 on Monday. The firm has a market cap of $3.43 million, a PE ratio of -0.26 and a beta of 1.95. Aethlon Medical has a twelve month low of $1.30 and a twelve month high of $5.00. The firm’s 50 day moving average price is $1.60 and its 200 day moving average price is $1.75.

Aethlon Medical (NASDAQ:AEMD) last released its quarterly earnings results on Wednesday, February 14th. The medical equipment provider reported ($1.37) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.23) by ($0.14). On average, sell-side analysts anticipate that Aethlon Medical will post -4.98 earnings per share for the current fiscal year.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.